BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 112041)

  • 1. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB; Lachmann PJ; Coombs RR
    Immunology; 1979 May; 37(1):25-34. PubMed ID: 112041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for activated C3 on thymus-dependent (T) lymphocytes of normal guinea-pigs.
    Wilson AB; Prichard-Thomas S; Coombs RR
    Immunology; 1979 Jun; 37(2):377-84. PubMed ID: 112046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activation of the alternative complement pathway by fetal calf serum and mouse thymocytes.
    Eisenberg RA; Theofilopoulos AN; Dixon FJ
    J Immunol; 1979 May; 122(5):2045-51. PubMed ID: 87451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-covalently bound C3 enhances lysis of rabbit erythrocytes through the alternative pathway.
    Hidvégi T; Füst G; Rajnavölgyi E; Kulics J; Gergely J
    Immunology; 1985 Dec; 56(4):735-41. PubMed ID: 3935572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosette formation by guinea pig thymocytes and thymus derived lymphocytes with rabbit red blood cells.
    Stadecker MJ; Bishop G; Wortis HH
    J Immunol; 1973 Dec; 111(6):1834-7. PubMed ID: 4201559
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody-independent complement activation by a subpopulation of mitogen-induced human T lymphoblasts.
    Martin MJ; Vega J; Gutiérrez C
    Immunology; 1980 Nov; 41(3):535-9. PubMed ID: 7007209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative pathway of complement activation by stimulated T lymphocytes. I. Binding of C3 fragments.
    Sármay G; Ramos OF; Klein E; Kai C; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):969-74. PubMed ID: 3111862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixation in acute serum sickness: assembly of glomerular-bound C3-convertase.
    Bartolotti SR; Peters DK
    Clin Exp Immunol; 1979 Sep; 37(3):391-8. PubMed ID: 389495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative pathway of complement activation by human lymphoblastoid B and T cell lines.
    Praz F; Lesavre P
    J Immunol; 1983 Sep; 131(3):1396-9. PubMed ID: 6604099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative pathway of complement activation by stimulated T lymphocytes. II. Elevation of cytotoxic potential against complement receptor-carrying cell lines.
    Ramos OF; Sármay G; Eggertsen G; Nilsson B; Klein E; Gergely J
    Eur J Immunol; 1987 Jul; 17(7):975-9. PubMed ID: 3111863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
    Inada K
    Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for immunoglobulin and complement on human alveolar macrophages.
    Reynolds HY; Atkinson JP; Newball HH; Frank MM
    J Immunol; 1975 Jun; 114(6):1813-9. PubMed ID: 1127229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enumeration and isolation of rabbit T and B lymphocytes by using antibody-coated erythrocytes.
    Wilson BS; Teodorescu M; Dray S
    J Immunol; 1976 May; 116(5):1306-12. PubMed ID: 1083869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytes stimulated by allogeneic B cell lines cleave the third component of complement and fix C3 fragments. Their nonspecific lytic capacity is elevated against complement receptor type 2-carrying targets.
    Ramos OF; Algarra I; Sármay G; Yefenof E; Gergely J; Klein E
    J Immunol; 1989 Jan; 142(1):217-23. PubMed ID: 2521233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement-independent adherence of Escherichia coli to complement receptors in vitro.
    Fine DP; Harper BL; Carpenter ED; Davis CP; Cavallo T; Guckian JC
    J Clin Invest; 1980 Sep; 66(3):465-72. PubMed ID: 6105165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement receptor lymphocytes in the rabbit I. an SIg-negative subpopulation in the appendix.
    Green WR; Fanger MW
    J Immunol; 1976 Nov; 117(5 Pt.2):1805-11. PubMed ID: 993581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of immune precipitation by complement.
    Schifferli JA; Bartolotti SR; Peters DK
    Clin Exp Immunol; 1980 Nov; 42(2):387-94. PubMed ID: 6781802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rosette-formation with mouse erythrocytes. II. A marker for human B and non-T lymphocytes.
    Gupta S; Good RA; Siegal FP
    Clin Exp Immunol; 1976 Aug; 25(2):319-27. PubMed ID: 1085238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the turnover of the receptor for the third component of complement on human lymphoid cells.
    Rosso di San Secondo VE; Meroni PL; Fortis C; Tedesco F
    J Immunol; 1979 May; 122(5):1658-62. PubMed ID: 312848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple rosette assay for demonstration of complement receptor sites using complement-coated zymosan beads.
    Huber Ch; Wigzell H
    Eur J Immunol; 1976 Jun; 5(6):432-5. PubMed ID: 1086242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.